Trust Company’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.2K Hold
250
– – ﹤0.01% 431
2026
Q2
$19.8K Buy
+250
New +$18.8K ﹤0.01% 376

Other funds holding IONS

Trust Company's IONS Position: Q3 2026 in Review

Trust Company held its Ionis Pharmaceuticals (IONS) position steady in Q3 2026 at 250 shares worth $11.2K. The position accounts for ﹤0.01% of the portfolio, ranked #431.

Trust Company first reported a position in IONS in Q2 2026 and has held it in 2 quarters since. The position peaked at $19.8K in Q2 2026. 464 funds tracked by Wall St. Rank hold IONS as of Q3 2026.

  • Trust Company held 250 shares of Ionis Pharmaceuticals worth $11.2K as of Q3 2026.
  • Trust Company left its Ionis Pharmaceuticals share count unchanged in Q3 2026.
  • Ionis Pharmaceuticals made up ﹤0.01% of Trust Company's portfolio in Q3 2026, its #431 holding.
  • Trust Company first reported a position in Ionis Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
  • Trust Company's Ionis Pharmaceuticals position peaked at $19.8K in Q2 2026.
  • 464 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.

Based on Trust Company's 13F filing for Q3 2026, filed 9 Oct 2026.